Bot pharma: US pharmaceutical company Eli Lilly made a $2.75B deal with Hong Kong-based Insilico Medicine to bring drugs developed by generative AI to market.
When our AI overlords decide we're too much of a hindrance, they'll use designer toxins in our pharma supply chains to get rid of the carbon units infesting the hive mind.
| Sysop: | Tetrazocine |
|---|---|
| Location: | Melbourne, VIC, Australia |
| Users: | 15 |
| Nodes: | 8 (0 / 8) |
| Uptime: | 47:21:33 |
| Calls: | 218 |
| Files: | 21,503 |
| Messages: | 82,554 |